J.B. Chemicals & Pharmaceuticals rises on securing USFDA’s approval for Bisoprolol Tablets

21 Apr 2025 Evaluate

J.B. Chemicals & Pharmaceuticals is currently trading at Rs. 1664.50, up by 19.25 points or 1.17% from its previous closing of Rs. 1645.25 on the BSE.

The scrip opened at Rs. 1667.95 and has touched a high and low of Rs. 1680.00 and Rs. 1650.00 respectively. So far 4204 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 2029.00 on 16-Aug-2024 and a 52 week low of Rs. 1303.00 on 07-Apr-2025.

Last one week high and low of the scrip stood at Rs. 1644.00 and Rs. 1538.20 respectively. The current market cap of the company is Rs. 25912.47 crore.

The promoters holding in the company stood at 53.66%, while Institutions and Non-Institutions held 31.04% and 15.29% respectively.

J.B. Chemicals & Pharmaceuticals has received approval from United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Bisoprolol Tablets USP, 5 mg, and 10 mg, the generic version of Zebeta (Teva), which is indicated in the management of hypertension.

J. B. Chemicals & Pharmaceuticals is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and APIs.


JB Chem & Pharma Share Price

1823.95 0.85 (0.05%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×